Study to establish the effectiveness of Devil’s Claw as a treatment for osteoarthritis of the knee joint

The University of Southampton’s Complementary Medicine Research Unit is looking for volunteers to take part in a new study which aims to establish the effectiveness of a well-known herbal remedy as a treatment for osteoarthritis of the knee joint.

Devil’s Claw, derived from the roots of a South African plant, is available over the counter in health food shops. This study will assess how effective the treatment is and identify the best dose to take.

Volunteers would need to attend the Wellcome Trust Research Facility at Southampton General Hospital on eight occasions and have a clinical examination, blood tests and an X-ray of their knee. To take part all volunteers should:

  • have been previously diagnosed with osteoarthritis of at least one knee joint by either their GP or consultant but not on a waiting list for a knee replacement joint
  • have had knee pain for more than three months and must have had knee pain each day during the past four weeks
  • be aged over 40.

For more information please contact Trish Boyle on 023 8024 1089/ 07739 249076 or email [email protected].

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds potential for antidiabetic drugs to modify osteoarthritis risk